+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Contract Manufacturing Market by Type, Function, Application - Global Forecast 2025-2030- Product Image
Vaccine Contract Manufacturing Market by Type, Function, Application - Global Forecast 2025-2030- Product Image
Sale

Vaccine Contract Manufacturing Market by Type, Function, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4857952
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vaccine Contract Manufacturing Market grew from USD 5.06 billion in 2023 to USD 5.51 billion in 2024. It is expected to continue growing at a CAGR of 9.21%, reaching USD 9.39 billion by 2030.

The scope of vaccine contract manufacturing encompasses providing outsourced production and scalable solutions for pharmaceutical companies, enabling efficient vaccine development and delivery, which is critical due to rising vaccine demand for preventing infectious diseases. As it bridges specialized expertise and scalable operations, the necessity stems from increasing global vaccination efforts accelerated by public health crises like the COVID-19 pandemic. Key applications comprise large-scale vaccine production for pharmaceutical firms lacking in-house capabilities and flexible manufacturing in response to sudden surges in demand. End-use sectors primarily include biotech and pharmaceutical companies, government health departments, and non-profit organizations focusing on public health. Influencing growth factors include technological advancements in manufacturing, governmental funding for vaccination programs, and growing public awareness. However, market growth faces challenges from stringent regulatory landscapes, high initial investment costs, and complexities associated with biosafety and cold chain logistics. Potential opportunities lie in embracing mRNA, vector-based vaccines, and integrating digital technologies like AI for process optimization. Collaborations and strategic partnerships can also significantly enhance competitive advantage. Expanding facilities in emerging markets presents lucrative prospects due to favorable manufacturing costs and untapped demand. However, staying abreast of regulatory changes and investing in robust supply chain systems are crucial to mitigate market limitations. Innovations in sustainable manufacturing processes and personalized vaccines for specific segments can unlock additional growth avenues. The market remains dynamic, characterized by rapid technological adoption and evolving global health needs, requiring stakeholders to remain adaptive and proactive. By investing in research and development, contract manufacturers can position themselves as key contributors to global health solutions, driving both business growth and societal benefits. Emphasizing agility, scalability, and compliance will be paramount for maintaining competitiveness in this rapidly evolving industry.

Understanding Market Dynamics in the Vaccine Contract Manufacturing Market

The Vaccine Contract Manufacturing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for vaccines leading to capacity expansion by contract manufacturers
    • Key advantages such as cost and time saving offered by contract services
    • Vaccination coverage across the globe
  • Market Restraints
    • Limited outsourcing by well-established vaccine manufacturers
  • Market Opportunities
    • Rising global demand to cater to the growing population of varied age groups
    • Innovation and robust vaccine pipeline
    • Favorable government insights and guidelines to speed up the vaccine manufacturing
  • Market Challenges
    • Pharma companies manufacturing operations in-house to gain strategic control

Exploring Porter’s Five Forces for the Vaccine Contract Manufacturing Market

Porter’s Five Forces framework further strengthens the insights of the Vaccine Contract Manufacturing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Vaccine Contract Manufacturing Market

External macro-environmental factors deeply influence the performance of the Vaccine Contract Manufacturing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Vaccine Contract Manufacturing Market

The Vaccine Contract Manufacturing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Vaccine Contract Manufacturing Market

The Vaccine Contract Manufacturing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Vaccine Contract Manufacturing Market

The Vaccine Contract Manufacturing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc, Ajinomoto Bio-Pharma Services by Ajinomoto Co., Inc., Aton (Shanghai) Biotech Co., Ltd., Avid Bioservices, Inc., Catalent, Inc., Charles River Laboratories International, Inc., CSL Limited, Curia Global, Inc., Cytovance Biologics by Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Emergent BioSolutions Inc., FUJIFILM Diosynth Biotechnologies U.S.A., Inc. by FUJIFILM Corporation, Gedeon Richter PLC, GlaxoSmithKline PLC, ICON PLC, IDT Biologika GmbH, KBI Biopharma, Inc. by JSR Corporation, Klocke Pharma-Service GmbH, Lonza Group Ltd., Merck KGaA, Moderna, Inc., Pfizer Inc., Pharmaceutical Product Development by Thermo Fisher Scientific Inc., Recipharm AB, Serum Institute of India, and Vetter Pharma-Fertigung GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Vaccine Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Attenuated Vaccine
    • DNA Vaccines
    • Inactivated Vaccine
    • Subunit Vaccines
    • Toxoid Vaccines
  • Function
    • Downstream
      • Analytical & QC studies
      • Fill & Finish Operations
      • Packaging
    • Upstream
      • Bacterial Expression Systems
      • Baculovirus or Insect Expression Systems
      • Mammalian Expression Systems
      • Yeast Expression Systems
  • Application
    • Human Use
    • Veterinary
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
5.1.1.2. Key advantages such as cost and time saving offered by contract services
5.1.1.3. Vaccination coverage across the globe
5.1.2. Restraints
5.1.2.1. Limited outsourcing by well-established vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Rising global demand to cater to the growing population of varied age groups
5.1.3.2. Innovation and robust vaccine pipeline
5.1.3.3. Favorable government insights and guidelines to speed up the vaccine manufacturing
5.1.4. Challenges
5.1.4.1. Pharma companies manufacturing operations in-house to gain strategic control
5.2. Market Segmentation Analysis
5.2.1. Type: Growing adoption of attenuated vaccines to enhance immune systems
5.2.2. Function: Increasing usage of downstream processing formulations that involve the purification and formulation of the bioproducts
5.2.3. Application: Rising potential of vaccine contract manufacturing for human use to protect populations against infectious diseases
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Vaccine Contract Manufacturing Market, by Type
6.1. Introduction
6.2. Attenuated Vaccine
6.3. DNA Vaccines
6.4. Inactivated Vaccine
6.5. Subunit Vaccines
6.6. Toxoid Vaccines
7. Vaccine Contract Manufacturing Market, by Function
7.1. Introduction
7.2. Downstream
7.3. Upstream
8. Vaccine Contract Manufacturing Market, by Application
8.1. Introduction
8.2. Human Use
8.3. Veterinary
9. Americas Vaccine Contract Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Vaccine Contract Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Vaccine Contract Manufacturing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumococcal Conjugate Vaccines (PCVs)
12.3.2. Oxford Acquires ABL Europe From Institut Mérieux For EUR 15 Mn
12.3.3. Pfizer Inks USD 183M Contract Manufacturing Deal With Samsung Biologics
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. VACCINE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VACCINE CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VACCINE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. VACCINE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QC STUDIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS OR INSECT EXPRESSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY BACULOVIRUS OR INSECT EXPRESSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY HUMAN USE, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY VETERINARY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 84. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 85. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 86. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 87. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 88. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 89. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CANADA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 94. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 95. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 96. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 97. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 98. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 99. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. MEXICO VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 138. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 139. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 140. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 141. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 142. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 143. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. CHINA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 148. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 149. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 150. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 151. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 152. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 153. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. INDIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 168. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 169. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 170. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 171. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 172. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 173. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. JAPAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 228. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 229. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 230. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 231. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 232. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 233. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. THAILAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 257. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 260. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 261. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 262. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 263. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 264. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 265. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. DENMARK VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 270. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 271. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 272. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 273. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 274. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 275. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. EGYPT VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 280. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 281. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 282. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 283. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 284. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 285. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. FINLAND VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 290. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 291. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 292. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 293. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 294. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 295. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. FRANCE VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 298. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 299. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 300. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 301. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 302. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 303. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 304. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 305. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. GERMANY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTION, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 318. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 319. ITALY VACCINE CONTRACT MANUFACTURING MARKET SIZE, BY FUNCTIO

Companies Mentioned

The leading players in the Vaccine Contract Manufacturing Market, which are profiled in this report, include:
  • AbbVie Inc
  • Ajinomoto Bio-Pharma Services by Ajinomoto Co., Inc.
  • Aton (Shanghai) Biotech Co., Ltd.
  • Avid Bioservices, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CSL Limited
  • Curia Global, Inc.
  • Cytovance Biologics by Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
  • Emergent BioSolutions Inc.
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc. by FUJIFILM Corporation
  • Gedeon Richter PLC
  • GlaxoSmithKline PLC
  • ICON PLC
  • IDT Biologika GmbH
  • KBI Biopharma, Inc. by JSR Corporation
  • Klocke Pharma-Service GmbH
  • Lonza Group Ltd.
  • Merck KGaA
  • Moderna, Inc.
  • Pfizer Inc.
  • Pharmaceutical Product Development by Thermo Fisher Scientific Inc.
  • Recipharm AB
  • Serum Institute of India
  • Vetter Pharma-Fertigung GmbH & Co. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.39 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report by Vaccine Type (Attenuated, Inactivated), Workflow (Downstream, Upstream), Application (Human, Veterinary), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report by Vaccine Type (Attenuated, Inactivated), Workflow (Downstream, Upstream), Application (Human, Veterinary), Region, and Segment Forecasts, 2024-2030

  • Report
  • 133 Pages
  • Global
From
Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region - Product Image

Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region

  • Report
  • 381 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report by Vaccine Type, Workflow, Application, and Region 2024-2032 - Product Image

Vaccine Contract Manufacturing Market Report by Vaccine Type, Workflow, Application, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Vaccine Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Vaccine Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 187 Pages
  • Global
From
Vaccine Contract Manufacturing - Global Strategic Business Report - Product Image

Vaccine Contract Manufacturing - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.